Tribute Pharmaceuticals Canada (TBUFF) Stock Price, News & Analysis

Company Overview

Tribute Pharmaceuticals Canada was a Canadian specialty pharmaceutical company focused on acquiring, developing and commercializing prescription and over-the-counter healthcare products. Its activities centered on identifying products with established clinical or commercial potential and expanding their availability through regulatory, marketing and distribution capabilities.

The company’s portfolio included products in areas such as urology, dermatology and other specialty-care markets. Tribute primarily served the Canadian healthcare market and also pursued opportunities to commercialize products in selected international markets through licensing and distribution arrangements.

Tribute Pharmaceuticals was acquired by Acerus Pharmaceuticals Corporation in 2016, after which it ceased operating as an independent publicly traded company. Because the company is no longer a standalone public issuer, current information about its leadership and operations is limited.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 50,100 shs
• Average Volume: 71,826 shs
• Market Capitalization: $105.76 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Last Earnings: 3/31/2014
• Today: 9/22/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:TBUFF
• CIK: N/A
• Web: www.stellarpharma.com
• Phone: +1-905-8761118
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 113,720,000
• Free Float: N/A
• Market Cap: $105.76 million
• Optionable: Not Optionable
• Beta: N/A